NCT00589927 - Triple Versus Dual Antiplatelet Therapy After ABT578-Eluting Stent | Biotech Hunter

Enrollment

486

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

February 28, 2010

Conditions

Coronary Artery Disease

Interventions

DRUG

cilostazol

cilostazol 200mg loading dose within 1 hours after successful stenting, followed by 100mg bid for 8 months

DRUG

placebo

placebo 200mg loading dose within 1 hours after successful stenting, followed by 100mg bid for 8 months

Trial Locations (10)

Soonchunhyang University Bucheon Hospital, Bucheon-si

Soonchunhyang University Hospital, Cheonan, Cheonan

Kangwon National University Hospital, Chuncheon

Chungnam National University Hospital, Daejeon

Hallym University Sacred Heart Hospital,, Pyeongchon

Hangang Sacred Heart Hospital, Seoul

Seoul Veterans Hospital, Seoul

Soonchunhyang University Seoul Hospital, Seoul

Ulsan University Hospital, Ulsan

Asan Medical Center, Seoul

All Listed Sponsors

collaborator

Otsuka Korea

UNKNOWN

lead

CardioVascular Research Foundation, Korea

OTHER